> it simply shouldn’t be possible with a proper approach to testing.
It just has to be delayed. Like many years after application. Or trigger on very specific and rare circumstances. Not likely in a trial, but near certain at a population scale.
Or both...
On top of that, If I remember correctly, this liability wavering also exist for Vaccines.
> It just has to be delayed. Like many years after application.
That's one thing. In this case, I don't really know if it's possible to test for something like delayed effects. I'm not even sure if you can identify them with 100% certainty; if you can prove that these effects come from this particular drug and not from another one.
> Or trigger on very specific and rare circumstances. Not likely in a trial, but near certain at a population scale.
And this is different thing. "Specific and rare circumstances" will not lead to millions of deaths (I apologize if I’m being too nitpicky about this particular phrasing, but I want to speak specifically in the context of “millions of deaths”). “Specific and rare circumstances” occur even with fully effective and "proper" medications - this is called “contraindications.” But such rare cases, as I’ve already said, will not lead to mass deaths - precisely because they are rare. I apologize again for focusing on the "millions", but please don’t confuse the scale of the problem.
I realize yours is the hip and edgy take but plenty of people have made a lot of money in the stock market without using material non public information.
Which is why "prompt injection" is just a flip side of intelligence in this sense. We want LLMs to be able to do risk/benefit analysis and act on it; we cry "security vulnerability" when it makes a different choice to the one we'd like it to. But you can't have the former without the possibility of the latter.
reply